A Study to Assess Safety and Efficacy of a Novel Patch Infusor Device and Novel SUBCUTaneous Furosemide Formulation Combination in Patients With Heart Failure

NCT04846816 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

COMBINATION_PRODUCT: SQIN-01

Sponsor

SQ Innovation, Inc.

Collaborators

[object Object]
[object Object]